Study Throws New Light On Cardiovascular Effectiveness Of Diabetes Drug Victoza

Novo Nordisk's (NVO) diabetes drug Victoza is linked to lower risk of myocardial infarction, stroke or cardiovascular death in a broader patient population, suggests a Nordic study.

from RTT - Biotech https://ift.tt/2zLkeGC
via IFTTT